Oncogenic pathway driven by p85β: upstream signals to activate p110

Area of Science:

• Cellular signaling pathways
• Molecular biology
• Cancer research

Background:

• Phosphatidylinositol 3-kinase (PI3K) is a key signaling enzyme downstream of receptor tyrosine kinases (RTKs).
• PI3K consists of regulatory (p85) and catalytic (p110) subunits, crucial for cell growth and survival.
• RTKs, like AXL, play vital roles in cellular communication and are often implicated in cancer.

Purpose of the Study:

• To investigate the regulatory relationship between PI3K and RTKs.
• To elucidate the specific role of the p85β regulatory subunit of PI3K in RTK signaling.
• To determine if PI3K and RTK pathways exhibit bidirectional cross-talk.

Main Methods:

• Western blotting to assess protein levels of AXL and PI3K subunits.
• Co-immunoprecipitation assays to study protein-protein interactions.
• Cell-based assays to evaluate PI3K activation.

Main Results:

• The p85β subunit of PI3K was found to increase the protein stability and expression of AXL, a receptor tyrosine kinase.
• Increased AXL levels led to enhanced activation of the p110 catalytic subunit of PI3K.
• These findings suggest a novel mechanism of positive feedback from PI3K to RTK.

Conclusions:

• The PI3K and RTK signaling pathways are bidirectionally regulated.
• p85β plays a critical role in stabilizing AXL, thereby promoting PI3K pathway activation.
• This cross-talk may represent a significant mechanism in cellular processes and disease states.